Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV Infection

Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and pneumonia in infants. Effective treatment for RSV infection is a significant unmet medical need. While new RSV therapeutics are now in development, there are very few animal models that mimic the pathogenesis of human RSV, m...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Jordan, Robert, Shao, Matt, Mackman, Richard L., Perron, Michel, Cihlar, Tomas, Lewis, Sandy A., Eisenberg, Eugene J., Carey, Anne, Strickley, Robert G., Chien, Jason W., Anderson, Mark L., McEligot, Heather A., Behrens, Nicole E., Gershwin, Laurel J.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2015
Sujets:
Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4505261/
https://ncbi.nlm.nih.gov/pubmed/26055364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00487-15
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires